BOSTON--(BUSINESS WIRE)--March 7, 2006--Point Therapeutics, Inc. (NASDAQ: POTP), announced today that it will release fourth quarter and fiscal year 2005 results on Tuesday, March 14, 2006, after the close of the U.S. financial markets. A conference call will follow at 4:30 PM Eastern Time, to review the results and provide an update on the Company’s progress. Additionally, Point will discuss the recent Keystone Symposium presentation on the Company’s type 2 diabetes program (PT-630). The Keystone presentation is available for review by visiting the investor relations page at www.pther.com.
